A comprehensive league table of cost-utility ratios and a sub-table of "Panel-worthy" studies

被引:124
作者
Chapman, RH
Stone, PW
Sandberg, EA
Bell, C
Neumann, PJ
机构
[1] Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Program Econ Evaluat Med Technol, Boston, MA 02115 USA
[2] Univ Rochester, Sch Nursing Community & Prevent Med, Rochester, NY USA
[3] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[4] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA
关键词
cost-utility analysis; league tables; economic evaluation;
D O I
10.1177/0272989X0002000409
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives. The authors compiled a comprehensive league table of cost/QALY ratios, and a standardized table of analyses satisfying selected Reference Case criteria from the USPHS Panel on Cost-Effectiveness in Health and Medicine. Methods. They identified 228 cost-utility analyses (CUAs) through literature searches, and abstracted data on methods and cost-utility ratios. The subset of "Panel-worthy" analyses used: a societal or broad health-care perspective, community or patient preference weights, net costs, incremental comparisons, and discounting of costs and QALYs. Results. The 228 CUAs included ratios for 647 interventions, ranging from cost-saving to $52,000,000/QALY (median = $12,0001QALY). The standardized table presents 112 ratios that met the "Panel-worthy" criteria, with articles published in recent years more likely to meet all of the criteria. Conclusions. The comprehensive league table (available on the Web) provides a useful reference, but ratios may not be comparable because of methodologic variations. The standardized table focuses on studies meeting basic methodologic criteria, potentially allowing for better comparison with future Reference Case analyses. Future studies should investigate the quality of analyses' underlying assumptions in addition to whether certain key procedural protocols were met.
引用
收藏
页码:451 / 467
页数:17
相关论文
共 65 条
  • [1] AARON HJ, 1994, HLTH AFFAIRS WIN, P8
  • [2] ECONOMIC-ANALYSIS IN RANDOMIZED CONTROL TRIALS
    ADAMS, ME
    MCCALL, NT
    GRAY, DT
    ORZA, MJ
    CHALMERS, TC
    [J]. MEDICAL CARE, 1992, 30 (03) : 231 - 243
  • [3] [Anonymous], 1996, GUID CLIN PREV SERV
  • [4] Barry HC, 1997, J FAM PRACTICE, V44, P49
  • [5] Methodologic evaluation of the radiology cost-effectiveness literature
    Blackmore, CC
    Magid, DJ
    [J]. RADIOLOGY, 1997, 203 (01) : 87 - 91
  • [6] BRIGGS A, 1995, HEALTH ECON, V4, P335
  • [7] COST-EFFECTIVENESS OF BREAST-CANCER SCREENING - PRELIMINARY-RESULTS OF A SYSTEMATIC REVIEW OF THE LITERATURE
    BROWN, ML
    FINTOR, L
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1993, 25 (02) : 113 - 118
  • [8] A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip
    Chang, RW
    Pellissier, JM
    Hazen, GB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11): : 858 - 865
  • [9] A COST-UTILITY ANALYSIS OF TREATMENT OPTIONS FOR GALLSTONE DISEASE - METHODOLOGICAL ISSUES AND RESULTS
    COOK, J
    RICHARDSON, J
    STREET, A
    [J]. HEALTH ECONOMICS, 1994, 3 (03) : 157 - 168
  • [10] Pharmacoeconomic studies - Pitfalls and problems
    DeGraeve, D
    Nonneman, W
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1996, 12 (01) : 22 - 30